"Mixing triptans": Patient satisfaction

Headache

Volumn 51, Issue 1, 2011, Pages 135-140

  Rothrock, John F ^a   Morey, Veronica ^b  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

injectable sumatriptan; migraine; triptans

Indexed keywords

ALMOTRIPTAN; ELETRIPTAN; FROVATRIPTAN; NARATRIPTAN; RIZATRIPTAN; SUMATRIPTAN; ZOLMITRIPTAN;

5 POINT LIKERT SCALE; ADULT; ARTICLE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, ORAL; ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PATIENT SATISFACTION; TREATMENT FAILURE; TRYPTAMINES; YOUNG ADULT;

EID: 78650954058     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2010.01819.x     Document Type: Article

References (16)

1. Cady R, Lipton R, Hall C, Stewart W, O'Quinn S,. Treatment of mild headache in disabled migraine sufferers: Results of the spectrum study. Headache. 2000; 40: 792-797.
2. Edvinsson L, Uddman E, Wackenfors A,. Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: Relationship to clinical effect. Clin Sci (Lond). 2005; 109: 335-342.
3. Watanabe Y, Tanaka H, Dan I, et al. Monitoring cortical hemodynamic changes after sumatriptan injection during migraine attack by near-infrared spectroscopy. Neurosci Res. 2010; available on-line (not yet in print).
4. Dodick D, Lipton R, Martin V, Papademetriou V, Rosamond W, Van den Brink A, et al. Consensus statement: Cardiovascular safety profile of triptans (5-HT 1B/1D Agonists) in the acute treatment of migraine. Headache. 2004; 44: 414-425.
5. Velentgas P, Cole J, Sikes C, Walker A,. Severe vascular events in migraine patients. Headache. 2004; 44: 642-651.
6. O'Quinn S, Davis RL, Gutterman DL, Pait GD, Fox A,. Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine. Cephalalgia. 1999; 19: 223-231.
7. Hall GC, Brown MM, Mo J, MacRae KD,. Triptans in migraine. The risks of stroke, cardiovascular disease, and death in practice. Neurology. 2004; 62: 563-568.
8. Cady RK, Wendt JR, Kirchner JR, Sargent JD, Rothrock JF, Skaggs H,. Treatment of acute migraine headaches with subcutaneous sumatriptan. JAMA. 1991; 2831-2835.
9. Humphrey PP, Goadsby PJ,. The mode of action of sumatriptan is vascular? A debate. Cephalalgia. 1994; 14: 401-410.
10. Rothrock J,. "Outside-in" vs "inside-out": Re-visiting migraine's vascular hypotheses. Headache 2008; 48: 1409-1410.
11. Cutrer FM, Charles M,. The neurologic basis of migraine. Headache 2008; 48: 1411-1414.
12. Brennan K, Charles A,. An update on the blood vessel in migraine. Curr Opin Neurol. 2010; 23: 266-274.
13. Kaniecki RG,. Mixing sumatriptan: A prospective study of stratified care using multiple formulations. Headache. 2001; 41: 862-866.
14. Berges A, Walls C, Lener SE, McDonald SA,. Pharmacokinetics and tolerability of sumatriptan after single-dose administration of a fixed-dose combination tablet of sumatriptan/naproxen sodium 85/500 mg followed two hours later by subcutaneous sumatriptan 4- or 6-mg injection; a randomized, open-label, three-period crossover study in healthy volunteers. Clin Ther. 2010; 32: 1165-1177.
15. Zebenholzer K, Wober C, Vigil M, Wessely P,. Eletriptan for the short-term prophylaxis of cluster headache. Headache. 2004; 44: 361-364.
16. Conway S, Rothrock J,. Mixing triptans: Co-prescription and use of injectable sumatriptan and an oral triptan other than sumatriptan. Neurology. 2006; 66 (Suppl. 2): A42.